Screener
Bristol-Myers Squibb BMY Short-Term Borrowings
Short-Term Borrowings at other companies
Other financials
Where this comes from
Reported directly by Bristol-Myers Squibb in its filing.
Tagged under the XBRL concept us-gaap:ShortTermBorrowings.
The source filing: Bristol-Myers Squibb’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 11:10 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000014272-26-000020
FAQ
- What is Bristol-Myers Squibb's short-term borrowings?
- Bristol-Myers Squibb (BMY) reported short-term borrowings of $1.03B in Q2 2026.
- How has Bristol-Myers Squibb's short-term borrowings changed year-over-year?
- Bristol-Myers Squibb's short-term borrowings decreased by 78.2% year-over-year, from $4.72B to $1.03B.
- What is the long-term trend for Bristol-Myers Squibb's short-term borrowings?
- Over 5 years (2020 to 2025), Bristol-Myers Squibb's short-term borrowings has grown at a -0.7% compound annual growth rate (CAGR), from $2.34B to $2.26B.
- What does short-term borrowings mean?
- Bank lines of credit, revolving credit facilities, and other short-term debt instruments with maturities under one year.
Ask your AI about Bristol-Myers Squibb's short-term borrowings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude